Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Neurones stock

NRO.PA
FR0004050250
938282

Price

43.90
Today +/-
-0.30
Today %
-0.68 %

Neurones stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Neurones stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Neurones stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Neurones stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Neurones's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Neurones Stock Price History

DateNeurones Price
12/24/202443.90 undefined
12/23/202444.20 undefined
12/20/202443.60 undefined
12/19/202443.80 undefined
12/18/202444.40 undefined
12/17/202444.30 undefined
12/16/202444.55 undefined
12/13/202444.40 undefined
12/12/202443.65 undefined
12/11/202444.00 undefined
12/10/202443.35 undefined
12/9/202443.25 undefined
12/6/202444.55 undefined
12/5/202444.15 undefined
12/4/202444.30 undefined
12/3/202445.20 undefined
12/2/202443.90 undefined
11/29/202444.90 undefined
11/28/202444.95 undefined
11/27/202444.70 undefined
11/26/202445.25 undefined

Neurones Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Neurones, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Neurones from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Neurones’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Neurones. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Neurones’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Neurones’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Neurones’s growth potential.

Neurones Revenue, EBIT and net profit per share

DateNeurones RevenueNeurones EBITNeurones Net Income
2026e784.01 M undefined96.43 M undefined61.31 M undefined
2025e861.13 M undefined95.34 M undefined58.85 M undefined
2024e809.01 M undefined80.8 M undefined51.5 M undefined
2023741.18 M undefined74.69 M undefined49.41 M undefined
2022665.38 M undefined72.22 M undefined44.24 M undefined
2021579.88 M undefined61.64 M undefined37.71 M undefined
2020524.49 M undefined51.89 M undefined30.92 M undefined
2019510.07 M undefined49.07 M undefined30.8 M undefined
2018490.08 M undefined45.81 M undefined25.96 M undefined
2017485.01 M undefined44.31 M undefined27.31 M undefined
2016446.76 M undefined42.72 M undefined25.2 M undefined
2015399.37 M undefined37.18 M undefined21.36 M undefined
2014355.17 M undefined35.8 M undefined20.51 M undefined
2013343.2 M undefined32.9 M undefined18.6 M undefined
2012315.4 M undefined27.9 M undefined14.8 M undefined
2011283.3 M undefined26.3 M undefined14.8 M undefined
2010239.6 M undefined24.6 M undefined13.2 M undefined
2009216.4 M undefined19.4 M undefined11.3 M undefined
2008189.3 M undefined18.4 M undefined12 M undefined
2007156 M undefined13.9 M undefined9.2 M undefined
2006130 M undefined9.3 M undefined6.1 M undefined
2005108.9 M undefined8.8 M undefined5.9 M undefined
200497.1 M undefined7.3 M undefined4.7 M undefined

Neurones Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
556685929297108130156189216239283315343355399446485490510524579665741809861784
-20.0028.798.24-5.4311.3420.3720.0021.1514.2910.6518.4111.318.893.5012.3911.788.741.034.082.7510.5014.8511.439.186.43-8.94
74.5581.8290.5988.0491.3092.7892.5993.8594.2395.2496.3097.4996.1197.1497.6797.1896.4997.7697.9499.8099.8071.18100.0099.8599.8791.4785.9594.39
415477818490100122147180208233272306335345385436475489509373579664740000
23554456912111314141820212527253030374449515861
-50.0066.67--20.00-25.0020.0050.0033.33-8.3318.187.69-28.5711.115.0019.058.00-7.4120.00-23.3318.9211.364.0813.735.17
----------------------------
----------------------------
19.322.822.822.823.922.823.724.124.223.823.523.724242424.2324.1424.2624.2924.2724.2924.2824.2524.2924.31000
----------------------------
Details

Keystats

Revenue and Growth

The Neurones Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Neurones is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (k)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                 
3.227.935.63641.246.650.548.45754.860.468.675.587.299.3121.82130.31139.97153.2173.78218.29266.06264.76271.79296.99
1819.824.32422.326.828.136.942.555.850.359.67684.790.992.38102.07120.72127.28133.97131.07129.36136.59165.29173.5
1.22.322.93.43.55.49.21011.2131524.626.635.635.7946.8652.558.7967.7154.5846.2153.0659.5662.57
1,000300300300100300200100200300300100400200200172409245891278385635887353709
00000000001.71.82.73.33.13.364.365.26.267.638.496.88.839.5812.04
23.450.362.263.26777.284.294.6109.7122.1125.7145.1179.2202229.1253.52284.01318.63346.42383.38412.81449.07464.13506.57545.81
1.31.41.61.51.61.51.62.133.73.64.25.66.37.78.2814.5914.516.2316.2147.1546.6446.148.7758.73
0.30.40.60.70.810.60.80.93.744.42.12.633.710.865.875.826.677.247.978.289.5210.75
0000000000000000000000031.930
0.10.20.21.71.720.50.40.50.70.50.30.50.30.20.122.211.580.80.13-0.140.941.160.761.2
0.410.19.911.811.110.913.618.520.734.534.234.536.136.536.536.4637.742.9740.5940.4740.4742.6944.745.3151.67
0000000.51.90.61.11.11.51.92.42.22.091.812.091.832.192.62.533.455.286.1
2.112.112.315.715.215.416.823.725.743.743.444.946.248.149.650.6567.186765.2765.6897.33100.78103.69141.58128.44
25.562.474.578.982.292.6101118.3135.4165.8169.1190225.4250.1278.7304.17351.2385.63411.69449.06510.14549.85567.82648.15674.25
                                                 
7.79.19.19.19.19.19.39.39.49.29.49.49.49.59.69.599.699.79.79.719.719.699.699.699.71
028.528.528.528.528.729.429.730.128.230.430.73131.131.131.1631.3831.4231.4231.4131.4131.4131.431.431.38
0.94.49.715.319.824.53035.143.253.962.274.189103.6121.1139.75157.35175.92201.85225.71256.05281.53270.47289.49313.3
0000000000000000000000274.38290.920
0000000000000000000000000
8.64247.352.957.462.368.774.182.791.3102114.2129.4144.2161.8180.5198.42217.04242.97266.83297.17322.63585.94621.5354.39
15.417.824.524.422.327.928.737.844.160.510.91114.516.31916.7329.7726.229.3831.2531.0432.6637.7342.9344.04
000000000043.650.361.669.172.77581.3290.3189.5391.7392.4594.32103.12114.6125.19
0000000.91.23.14.24.96.69.48.71114.4819.9926.9122.0628.3825.8827.5136.2241.4146.64
00000000.30.32.20.60.20.40.10.20.20.310.550.470.370.160.110.10.092.31
1.21.81.90.20.500.6000.10.10.10000.161.271.280.6806.96.837.48.0710.74
16.619.626.424.622.827.930.239.347.56760.168.285.994.2102.9106.57132.66145.25142.13151.74156.43161.43184.56207.1228.92
00.100000000.10.1000001.890.860.24024.5727.2327.8327.4130.93
00002000000020000000000100000
0.10.20.20.20.30.40.12.421.70.40.40.30.40.60.720.91.071.281.441.822.162.526.136.5
0.10.30.20.20.50.40.12.421.80.70.40.30.40.60.722.791.931.521.4426.3929.3930.3433.5337.42
16.719.926.624.823.328.330.341.749.568.860.868.686.294.6103.5107.29135.45147.18143.64153.18182.82190.83214.9240.64266.34
25.361.973.977.780.790.699115.8132.2160.1162.8182.8215.6238.8265.3287.79333.87364.22386.61420.01479.99513.45800.84862.14620.73
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Neurones provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Neurones's financial health and stability.

Assets

Neurones's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Neurones must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Neurones after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Neurones's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
335545669121214171721232429312935344251
0011111112232455568715151416
00000001,0001,000000000000000000
-102-110-1-520-1-3-9-2-600-13-14-514164-16
000000000100-100-10-1-10-3012
000000000000000000000000
01-21013316118131215141416201814141624
239687541516151581920283021233161676454
00-1-1-1-10-1-2-2-2-2-4-4-5-5-12-6-8-6-7-7-6-10
-1-9-1-4-3-1-1-5-5-16-6-5-1-6-6-6-24-11-9-9-8-8-10-12
0-80-2-20-1-3-2-14-3-23-1-10-12-40-200-4-1
000000000000000000000000
00000000000000003-1-10-6-6-6-7
0290000100-200000000000-100
02900000-1-1-4-2-10000200-1-9-11-55-36
00000000000000101221-110-4
000000-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-4-48-24
02371453-28-47861213228913204348-16
1.232.488.154.37.076.374.752.2412.9114.3913.4112.683.4114.7414.5223.2917.2114.2814.3124.1153.4360.157.9244.36
000000000000000000000000

Neurones stock margins

The Neurones margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Neurones. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Neurones.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Neurones's sales revenue. A higher gross margin percentage indicates that the Neurones retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Neurones's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Neurones's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Neurones's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Neurones. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Neurones's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Neurones Margin History

Neurones Gross marginNeurones Profit marginNeurones EBIT marginNeurones Profit margin
2026e99.89 %12.3 %7.82 %
2025e99.89 %11.07 %6.83 %
2024e99.89 %9.99 %6.37 %
202399.89 %10.08 %6.67 %
202299.92 %10.85 %6.65 %
202199.93 %10.63 %6.5 %
202071.26 %9.89 %5.89 %
201999.91 %9.62 %6.04 %
201899.91 %9.35 %5.3 %
201797.95 %9.14 %5.63 %
201697.8 %9.56 %5.64 %
201596.54 %9.31 %5.35 %
201497.36 %10.08 %5.77 %
201397.61 %9.59 %5.42 %
201297.15 %8.85 %4.69 %
201196.05 %9.28 %5.22 %
201097.58 %10.27 %5.51 %
200996.16 %8.96 %5.22 %
200895.19 %9.72 %6.34 %
200794.23 %8.91 %5.9 %
200694.31 %7.15 %4.69 %
200592.56 %8.08 %5.42 %
200492.79 %7.52 %4.84 %

Neurones Stock Sales Revenue, EBIT, Earnings per Share

The Neurones earnings per share therefore indicates how much revenue Neurones has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Neurones earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Neurones's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Neurones’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Neurones's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Neurones Revenue, EBIT and net profit per share

DateNeurones Sales per ShareNeurones EBIT per shareNeurones Earnings per Share
2026e32.29 undefined0 undefined2.53 undefined
2025e35.47 undefined0 undefined2.42 undefined
2024e33.32 undefined0 undefined2.12 undefined
202330.48 undefined3.07 undefined2.03 undefined
202227.39 undefined2.97 undefined1.82 undefined
202123.92 undefined2.54 undefined1.56 undefined
202021.6 undefined2.14 undefined1.27 undefined
201921 undefined2.02 undefined1.27 undefined
201820.19 undefined1.89 undefined1.07 undefined
201719.97 undefined1.82 undefined1.12 undefined
201618.41 undefined1.76 undefined1.04 undefined
201516.54 undefined1.54 undefined0.88 undefined
201414.66 undefined1.48 undefined0.85 undefined
201314.3 undefined1.37 undefined0.78 undefined
201213.14 undefined1.16 undefined0.62 undefined
201111.8 undefined1.1 undefined0.62 undefined
201010.11 undefined1.04 undefined0.56 undefined
20099.21 undefined0.83 undefined0.48 undefined
20087.95 undefined0.77 undefined0.5 undefined
20076.45 undefined0.57 undefined0.38 undefined
20065.39 undefined0.39 undefined0.25 undefined
20054.59 undefined0.37 undefined0.25 undefined
20044.26 undefined0.32 undefined0.21 undefined

Neurones business model

Neurones SA is a French company specializing in IT services and consulting. It was founded in 1989 and is based in Paris. With over 10,000 employees worldwide, the company operates in over 20 countries and serves clients in various industries such as healthcare, finance, telecommunications, and the public sector. Neurones SA's business model is based on developing and implementing IT projects and providing consulting and support services tailored to its clients' specific needs. The company's divisions include management consulting, system integration, maintenance, and technology services. Its product portfolio includes solutions in CRM, ERP, CMS, as well as cloud computing, cybersecurity, and data analytics. Neurones SA's key products are the Neurones AI Suite, which utilizes AI and machine learning to automate business processes and improve decision-making, and the Smart Health Platform, a cloud-based platform for the healthcare industry. The company's clients include Air France, L'Oréal, PSA Peugeot Citroën, and Orange. Neurones SA emphasizes customer loyalty, with over 80% of its clients being long-term customers. Overall, Neurones SA is a leading IT company that specializes in providing tailored IT solutions and consulting services, and it is well-positioned for future success with its global presence and diverse range of products and services. Neurones is one of the most popular companies on Eulerpool.com.

Neurones SWOT Analysis

Strengths

Neurones SA has several strengths that contribute to its success in the market. These include:

  • Strong market presence and brand reputation
  • Diverse portfolio of innovative products and services
  • Skilled and experienced workforce
  • Solid financial performance and stability

Weaknesses

Despite its strengths, Neurones SA also faces certain weaknesses that it should address for further growth:

  • Limited geographical presence in certain markets
  • Reliance on a few key clients for a significant portion of revenue
  • Potential vulnerability to economic downturns
  • Higher operational costs compared to some competitors

Opportunities

Neurones SA can capitalize on several opportunities to expand and enhance its business:

  • Growing demand for digital transformation services
  • Emerging markets with untapped potential
  • Strategic partnerships and collaborations
  • Increasing trend towards outsourcing IT services

Threats

There are various external factors that may pose challenges to Neurones SA:

  • Intense competition from established and new players
  • Rapid technological advancements that require continuous adaptation
  • Regulatory changes impacting the industry
  • Economic and market uncertainties affecting client spending
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Neurones Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Neurones historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Neurones shares outstanding

The number of shares was Neurones in 2023 — This indicates how many shares 24.313 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Neurones earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Neurones's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Neurones’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Neurones's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Neurones dividend history and estimates

In 2023, Neurones paid a dividend amounting to 1.1 EUR. Dividend means that Neurones distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Neurones provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Neurones’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Neurones's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Neurones Dividend History

DateNeurones Dividend
2026e1.14 undefined
2025e1.15 undefined
2024e1.12 undefined
20231.1 undefined
20221 undefined
20212 undefined
20200.2 undefined
20190.06 undefined
20180.06 undefined
20170.06 undefined
20160.06 undefined
20150.06 undefined
20140.06 undefined
20130.06 undefined
20120.06 undefined
20110.06 undefined
20100.07 undefined
20090.07 undefined
20080.07 undefined
20070.06 undefined
20060.06 undefined
20050.05 undefined

Neurones dividend payout ratio

In 2023, Neurones had a payout ratio of 66.41%. The payout ratio indicates the percentage of the company's profits that Neurones distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Neurones represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Neurones could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Neurones's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Neurones Payout Ratio History

DateNeurones Payout ratio
2026e72.64 %
2025e68.21 %
2024e83.31 %
202366.41 %
202254.9 %
2021128.61 %
202015.71 %
20194.73 %
20185.61 %
20175.36 %
20165.77 %
20156.82 %
20147.09 %
20137.79 %
20129.68 %
20119.68 %
201012.5 %
200914.58 %
200813.73 %
200715.79 %
200623.08 %
200520 %
200466.41 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Neurones.

Neurones shareholders

%
Name
Stocks
Change
Date
59.56112 % Chammard Family14,461,44006/7/2024
5.20636 % Neurones SA Management1,264,10306/7/2024
4.98395 % Invesco Advisers, Inc.1,210,103-46,4455/27/2024
4.14745 % Family (Bertrand Ducurtil)1,007,00006/7/2024
1.60968 % La Financi¿re de l'Echiquier390,83008/31/2024
1.05589 % Allianz Global Investors GmbH256,37008/31/2024
0.97467 % Neurones SA Employees236,65006/7/2024
0.61429 % Grandeur Peak Global Advisors, LLC149,150-21,8267/31/2024
0.57893 % Fidelity Institutional Asset Management140,56524,9318/31/2024
0.55000 % Janus Henderson Investors133,53909/30/2024
1
2
3
4
5
...
6

Neurones Executives and Management Board

Mr. Luc De Chammard

(67)
Neurones Chairman of the Board, Chief Executive Officer (since 1984)
Compensation 240,000

Mr. Bertrand Ducurtil

(63)
Neurones Executive Vice President (since 1999)
Compensation 240,000

Mr. Herve Pichard

(68)
Neurones Director
Compensation 5,000

Mr. Jean-Louis Pacquement

(68)
Neurones Independent Director
Compensation 5,000

Ms. Daphne De Chammard

(74)
Neurones Director - Representative of Host Developpement
Compensation 4,000
1
2

Neurones Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
EASYVISTA SA Stock
EASYVISTA SA
SupplierCustomer 0,200,12-0,19
SupplierCustomer0,760,570,200,25-0,260,14
SupplierCustomer0,74-0,20-0,08-0,250,640,90
SupplierCustomer0,710,110,420,31-0,02-0,10
SupplierCustomer0,710,770,470,31-0,480,62
SupplierCustomer0,690,400,490,25-0,04-0,03
SupplierCustomer0,690,820,700,040,280,85
SupplierCustomer0,680,440,370,29-0,690,37
SupplierCustomer0,650,790,430,130,340,69
SupplierCustomer0,640,230,230,21-0,220,51
1
2
3
4

Most common questions regarding Neurones

What values and corporate philosophy does Neurones represent?

Neurones SA represents a strong set of values and a clear corporate philosophy. The company values include excellence, innovation, and commitment. Neurones SA strives for excellence in all areas of its business, ensuring high-quality services and solutions for its clients. The company fosters innovation, constantly seeking new ways to improve and adapt to the rapidly changing business landscape. Neurones SA also emphasizes commitment, both towards its clients and its employees, fostering strong and long-lasting relationships. Overall, Neurones SA prides itself on being a trustworthy and reliable partner, driven by its values and corporate philosophy.

In which countries and regions is Neurones primarily present?

Neurones SA is primarily present in France, where the company is headquartered. As a leading French IT services and consulting firm, Neurones SA has established a strong presence in various regions across the country. With a focus on delivering innovative solutions and expertise in digital transformation, Neurones SA has expanded its operations in other countries as well. While primarily present in France, the company also has a presence in other European countries, including Belgium, Luxembourg, and Switzerland. Neurones SA's commitment to providing cutting-edge technology solutions has allowed them to become a trusted partner for businesses not only in France but also in select international markets.

What significant milestones has the company Neurones achieved?

Some significant milestones achieved by Neurones SA include its creation in 1985, listing on the Paris Stock Exchange in 1999, and being recognized as a key player in digital transformation services. The company has consistently expanded its expertise in areas such as digital services, cybersecurity, and artificial intelligence. Neurones SA has also formed strategic partnerships and made numerous acquisitions to strengthen its position in the market. With a strong track record of delivering innovative solutions to its clients, the company continues to thrive and contribute to the advancement of technology-driven businesses.

What is the history and background of the company Neurones?

Neurones SA is a renowned French IT services company established in 1984. With over 30 years of experience, Neurones has become a leading player in the industry, delivering innovative digital solutions to a wide range of clients. Initially focused on mainframe computer services, the company quickly expanded its expertise to cover emerging technologies, such as internet and e-business solutions, as well as information systems security. Neurones SA delivers high-quality services encompassing consulting, systems integration, infrastructure management, and outsourcing. Through strategic partnerships, continuous innovation, and a talented workforce, Neurones SA has solidified its position as a trusted provider of IT solutions globally.

Who are the main competitors of Neurones in the market?

The main competitors of Neurones SA in the market include Atos, Capgemini, and Sopra Steria.

In which industries is Neurones primarily active?

Neurones SA is primarily active in the IT and management consulting industries.

What is the business model of Neurones?

The business model of Neurones SA revolves around providing IT services and solutions to various industries. Neurones SA offers a wide range of services including consulting, system integration, infrastructure management, and software solutions. The company focuses on developing innovative and cost-effective IT solutions to help their clients optimize their business processes and improve overall performance. Neurones SA aims to meet the evolving technology needs of its clients by staying updated with the latest advancements in the IT sector. With its expertise and experience, Neurones SA strives to deliver high-quality IT services and solutions tailored to the specific requirements of each client.

What is the P/E ratio of Neurones 2024?

The Neurones P/E ratio is 20.73.

What is the P/S ratio of Neurones 2024?

The Neurones P/S ratio is 1.32.

What is the Quality Investing of Neurones?

The Quality Investing for Neurones is 9/10.

What is the revenue of Neurones 2024?

The expected Neurones revenue is 809.01 M EUR.

How high is the profit of Neurones 2024?

The expected Neurones profit is 51.5 M EUR.

What is the business model of Neurones

The company Neurones SA is a large company that offers various services in the field of IT and digital transformation. The company was founded in 1989 and is headquartered in France. Neurones SA's services are used by companies of all sizes and industries. The business model of Neurones SA is based on three pillars: Professional Services, Software, and Transformation. Professional Services include consulting, planning, and implementation of IT projects. The company works in partnership with customers to develop and implement customized solutions for their business needs. Neurones SA also offers outsourcing services to facilitate the operation of IT systems for customers. The software division of Neurones SA includes products and solutions developed by the company. The main products include cybersecurity solutions to help customers protect their systems and data from threats. The company also offers software tools that can improve the efficiency of IT systems and reduce costs. These solutions are used by companies of all sizes and industries to optimize their business processes. The third pillar of Neurones SA's business model is transformation. The company believes that the digitalization of society and the economy requires transformation. This involves adapting business models and introducing new technologies to remain competitive. Neurones SA provides consulting and implementation services to support companies in their digital transformation. The company works with its customers to rethink business processes, introduce new technologies such as artificial intelligence and blockchain, and support employees in adapting to new work methods and tools. Neurones SA offers a wide range of services that are used by medium-sized companies to large multinational corporations in various industries. The company's broad portfolio allows it to meet the individual needs of each customer with its services. The company operates in Europe and North Africa and has a network of over 8,000 experts in various fields. Neurones SA's employees are highly qualified IT specialists, consultants, and project managers who work closely with customers to develop customized business solutions. In summary, Neurones SA's business model is based on three pillars: Professional Services, Software, and Transformation. With its wide range of services and products, the company has achieved a strong position in the market for IT consulting and digital transformation. The company works closely with its customers to develop customized solutions for their business needs. The company operates in Europe and North Africa and offers its customers a wide range of services ranging from consulting and planning to implementation and operation.

What is the Neurones dividend?

Neurones pays a dividend of 1 EUR distributed over payouts per year.

How often does Neurones pay dividends?

The dividend cannot currently be calculated for Neurones or the company does not pay out a dividend.

What is the Neurones ISIN?

The ISIN of Neurones is FR0004050250.

What is the Neurones WKN?

The WKN of Neurones is 938282.

What is the Neurones ticker?

The ticker of Neurones is NRO.PA.

How much dividend does Neurones pay?

Over the past 12 months, Neurones paid a dividend of 1.1 EUR . This corresponds to a dividend yield of about 2.51 %. For the coming 12 months, Neurones is expected to pay a dividend of 1.15 EUR.

What is the dividend yield of Neurones?

The current dividend yield of Neurones is 2.51 %.

When does Neurones pay dividends?

Neurones pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Neurones?

Neurones paid dividends every year for the past 22 years.

What is the dividend of Neurones?

For the upcoming 12 months, dividends amounting to 1.15 EUR are expected. This corresponds to a dividend yield of 2.61 %.

In which sector is Neurones located?

Neurones is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von Neurones kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Neurones from 6/14/2024 amounting to 1.2 EUR, you needed to have the stock in your portfolio before the ex-date on 6/12/2024.

When did Neurones pay the last dividend?

The last dividend was paid out on 6/14/2024.

What was the dividend of Neurones in the year 2023?

In the year 2023, Neurones distributed 1 EUR as dividends.

In which currency does Neurones pay out the dividend?

The dividends of Neurones are distributed in EUR.

All fundamentals about Neurones

Our stock analysis for Neurones Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neurones Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.